Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women

Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a significant global health issue. Autophagy plays a dual role in breast cancer, influencing both anti-tumor immunity and tumor progression. This study aimed to investigate the role of autophagy markers, specific...

Full description

Saved in:
Bibliographic Details
Main Authors: Noor Al Rubaiey, Hazima ALabassi
Format: Article
Language:English
Published: University of Kirkuk 2024-12-01
Series:Kirkuk Journal of Science
Subjects:
Online Access:https://kujss.uokirkuk.edu.iq/article_185826_d52817d15786413efe99369681c4c7b1.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841546536821981184
author Noor Al Rubaiey
Hazima ALabassi
author_facet Noor Al Rubaiey
Hazima ALabassi
author_sort Noor Al Rubaiey
collection DOAJ
description Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a significant global health issue. Autophagy plays a dual role in breast cancer, influencing both anti-tumor immunity and tumor progression. This study aimed to investigate the role of autophagy markers, specifically SDF1 and CXCR4, in breast cancer pathogenesis among Iraqi women.A total of 90 participants, aged 25–65 years, were divided into three groups: 30 newly diagnosed breast cancer patients, 30 patients undergoing chemotherapy, and 30 healthy controls. The chemotherapy regimen for the treated group included Adriamycin (60 mg/m²) combined with cyclophosphamide, administered in 21-day cycles. Diagnosis was confirmed through mammography and histopathological examination. Blood samples (3 ml) were collected, processed, and stored for analysis, with serum levels of SDF1 and CXCR4 measured using ELISA kits.The study revealed that SDF1 levels were significantly elevated in newly diagnosed patients (84.91 ± 4.2 pg/ml) compared to chemotherapy patients (59.94 ± 2.18 pg/ml) and controls (57.00 ± 3.47 pg/ml), with p≤0.001. Similarly, CXCR4 levels were highest in newly diagnosed patients (0.5 ± 0.06 ng/ml), followed by controls (0.11 ± 0.01 ng/ml) and chemotherapy patients (0.08 ± 0.01 ng/ml), also with p≤0.001. A moderate positive correlation between SDF1 and CXCR4 (r = 0.5, p = 0.001) was observed, indicating their potential role in breast cancer progression.These findings highlight the significance of SDF1 and CXCR4 as potential markers for understanding breast cancer pathogenesis and progression, offering insights for targeted therapeutic 
format Article
id doaj-art-ccb9e88a2f6d41feb570017ae2f3c9b7
institution Kabale University
issn 3005-4788
3005-4796
language English
publishDate 2024-12-01
publisher University of Kirkuk
record_format Article
series Kirkuk Journal of Science
spelling doaj-art-ccb9e88a2f6d41feb570017ae2f3c9b72025-01-10T16:36:34ZengUniversity of KirkukKirkuk Journal of Science3005-47883005-47962024-12-01194374910.32894/kujss.2024.153313.1180185826Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi WomenNoor Al Rubaiey0Hazima ALabassi1Department of Biology, College of Education for Pure Science (Ibn Al- Haitham), University of Baghdad, Baghdad, Iraq.Department of Biology, College of Education for Pure Science (Ibn Al-Haitham), University of Baghdad, Iraq , Baghdad .Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a significant global health issue. Autophagy plays a dual role in breast cancer, influencing both anti-tumor immunity and tumor progression. This study aimed to investigate the role of autophagy markers, specifically SDF1 and CXCR4, in breast cancer pathogenesis among Iraqi women.A total of 90 participants, aged 25–65 years, were divided into three groups: 30 newly diagnosed breast cancer patients, 30 patients undergoing chemotherapy, and 30 healthy controls. The chemotherapy regimen for the treated group included Adriamycin (60 mg/m²) combined with cyclophosphamide, administered in 21-day cycles. Diagnosis was confirmed through mammography and histopathological examination. Blood samples (3 ml) were collected, processed, and stored for analysis, with serum levels of SDF1 and CXCR4 measured using ELISA kits.The study revealed that SDF1 levels were significantly elevated in newly diagnosed patients (84.91 ± 4.2 pg/ml) compared to chemotherapy patients (59.94 ± 2.18 pg/ml) and controls (57.00 ± 3.47 pg/ml), with p≤0.001. Similarly, CXCR4 levels were highest in newly diagnosed patients (0.5 ± 0.06 ng/ml), followed by controls (0.11 ± 0.01 ng/ml) and chemotherapy patients (0.08 ± 0.01 ng/ml), also with p≤0.001. A moderate positive correlation between SDF1 and CXCR4 (r = 0.5, p = 0.001) was observed, indicating their potential role in breast cancer progression.These findings highlight the significance of SDF1 and CXCR4 as potential markers for understanding breast cancer pathogenesis and progression, offering insights for targeted therapeutic https://kujss.uokirkuk.edu.iq/article_185826_d52817d15786413efe99369681c4c7b1.pdftumorimmune responsesmetastasischemotherapy
spellingShingle Noor Al Rubaiey
Hazima ALabassi
Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women
Kirkuk Journal of Science
tumor
immune responses
metastasis
chemotherapy
title Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women
title_full Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women
title_fullStr Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women
title_full_unstemmed Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women
title_short Serum Levels of SDF-1 and CXCR4 in Breast Cancer: Correlation with Disease Progression and Chemotherapy Response in Iraqi Women
title_sort serum levels of sdf 1 and cxcr4 in breast cancer correlation with disease progression and chemotherapy response in iraqi women
topic tumor
immune responses
metastasis
chemotherapy
url https://kujss.uokirkuk.edu.iq/article_185826_d52817d15786413efe99369681c4c7b1.pdf
work_keys_str_mv AT nooralrubaiey serumlevelsofsdf1andcxcr4inbreastcancercorrelationwithdiseaseprogressionandchemotherapyresponseiniraqiwomen
AT hazimaalabassi serumlevelsofsdf1andcxcr4inbreastcancercorrelationwithdiseaseprogressionandchemotherapyresponseiniraqiwomen